A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines

Mario Campone*, Natalya Dobrovolskaya, Serjei Tjulandin, Shin Chen Chen, Sameul Fourie, Fawzia Mefti, Maria Konstantinova, Florence Lefresne, Nadege Meheust, Jacek Jassem

*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science